학술논문

Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC)
Document Type
Journal
Source
ANNALS OF ONCOLOGY; 2021, 32 pS602-pS603, 2p. Supplement: 5
Subject
Language
English
ISSN
15698041